Lee et al. found that activations of NF-kappa B and COX-2 contribute to IFN-α resistance in human A549 non-small cell lung cancer cells, but that can be reversed by addition of Curcumin [17, 18]. The gene discussed is IFNA1; the disease is non-small cell lung carcinoma.